Polytherapeutic approach using bilayer matrix technology

Article Sidebar

PDF
DOI: https://doi.org/10.22377/ajp.v8i2.351

Main Article Content

Sanjay Kumar Sharma
Shailender Mohan
Manish Jaimini
Rohit Tiwari

Abstract

Oral administration of the drug is the most popular route for systemic effects owing to its ease of ingestion, pain, versatility,
and most importantly, patient compliance. Combinational therapy have been found to have various advantages over
monotherapy such as problem of dose-dependent side effects is minimized, a low‑dose combination of two different agents
reduces the dose-related risk, the addition of one agent may counteract some deleterious effects of the other, using low dosage of two different agents minimize the clinical and metabolic effects that occur with maximal dosage of individual component of the combined tablet. Multilayer tableting is getting increasing attention from a variety of industries for a variety of reasons viz. patent extension, therapeutic, and marketing attendance. To reduce capital investment, quite often existing, but modified tablet presses are used to develop and produce such tablets. Although the general tablet manufacturing principles remain the same, there is much more to consider, since making multilayer tablets involves multiple often incompatible products, additional equipment, and many formulation and operation challenges.
Key words: Bilayer matrix, combination therapy, multilayer tabletting, polytherapy

Downloads

Download data is not yet available.

Article Details

How to Cite
Sharma, S. K., Mohan, S., Jaimini, M., & Tiwari, R. (2014). Polytherapeutic approach using bilayer matrix technology. Asian Journal of Pharmaceutics (AJP), 8(2). https://doi.org/10.22377/ajp.v8i2.351
Issue
Vol. 8 No. 2 (2014): Apr-Jun
Section
Articles

This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.

References

Bankar GS, Anderson NR. Tablets. In: Leon L, Liberman HA, Kaing JL,

editors. The Theory and Practice of Industrial Pharmacy. 3rd ed. Varghese

Publishing House; 1987. p. 293 ‑303.

Nangia A, Molloy T, Fahie BJ, Chopra SK. Novel regulated release

system based on geometric configuration. Proc Int Sym Con Rel Bio

Mat 1995;22:294‑5.

Chidambaram N, Porter W, Flood K, Qiu Y. Formulation and

characterization of new layered diffusional matrices for zero‑order

sustained release. J Control Release 1998;52:149‑58.

Conte U, Maggi L, Columbo P, La Manna A. Multi‑layered hydrophilic

matrices as constant release devices (Geomatrix Systems). J Control

Release 1993;26:39‑47.

Abdul S, Poddar SS. A flexible technology for modified release of drugs:

Multi layered tablets. J Control Release 2004;97:393‑405.

Podczeck F, Drake KR, Newton JM, Haririan I. The strength of bi‑layered

tablet. Eur J Pharm Sci 2006;29:361‑6.

Inman SJ, Briscoe BJ, Pitt KG. Topographic characterization of cellulose

bilayered tablets interfaces. Chem Eng Res Des 2007;85:1005‑12.

Jitendra R, Mohan A, Kalaskar G, Shrivastav VG, Yeole PG. Bilayer tablet

formulation of metformin hydrochloride and gliclazide: A novel approach

in the treatment of diabetes. Int J Pharma Res Dev 2009;1:1‑11.

Gunsel WC. Compression‑coated and layered tablets. In: Lieberman HA,

Lachman L, editors. Phramaceutical Dosage Forms: Tablets. Marcel Dekker.

Bogan RK. Treatment options for insomania‑‑pharmacodynamics of

zolpidem extended‑release to benefit next day performance. Postgrad

Med 2008;120:161‑71.

Kulkarni A, Bhatia M. Development and evaluation of bilayer floating

tablets of atenolo and lovastatin for biphasic release profile. Iranian J

Pharm Res 2009;8:15‑25.

Nirmal J, Saisivam S, Peddanna C, Muralidharan S, Godwinkumar S,

Nagarajan M. Bilayer tablets of atorvastatin calcium and nicotinic acid:

Formulation and evaluation. Chem Pharm Bull (Tokyo) 2008;56:1455‑8.

Efentakis M, Peponaki C. Formulation study and evaluation of

matrix and three‑layer tablet sustained drug delivery systems based

on carbopols with isosorbite mononitrate. AAPS PharmSciTech

;9:917‑23.

Phaechmud T. Variables influencing drug release from layered matrix

system comprising hydroxypropyl methylcellulose. AAPS PharmSciTech

;9:668‑74.

LaForce C, Gentile DA, Skoner DP. A randomized, double blind,

parallel group, multicenter, placebo‑controlled study of the safety and

efficacy of ER guaifensein/pseudoephedrine HCl for symptom relief

as an adjunctive therapy of antibiotic treatment of acute respiratory

infections. Postgrad Med 2008;120:53‑9.

Maggi L, Segale L, Conti S, Ochoa Machiste E, Conte U. Preparation

and evaluation of release characteristics of 3TabGum, a novel chewing

device. Eur J Pharm Sci 2005;4:487‑93.

Park CR, Munday DL. Development and evaluation of biphasic

buccal adhesive tablet for nicotine replacement therapy. Int J Pharm

;237:215‑26.

Sungthongjeen S, Srimornsak P, Puttipipatkhachorn S. Design and

evaluation of floating multilayered coated tablets based on gas

formation. Eur J Pharm Biopharm 2008;69:255‑63.

Kale SS, Saste VS, Prajkta L, Ughade, Dheeraj T, Bhaviskar, et al. Bilayer

tablet: Review. Int J Pharm Sci Rev Res 2011;9:25‑30.

Available from: http://www.port/technology.com [Last accessed

on July 1, 2012].

The Indian Pharmacopoeia. 4th ed, Vol. 2. The Controller of Publication,

Govt. of India, Delhi, 1996. p. A82‑A85.

The United States Pharmacopoeia, United States Pharmacopoeial

Convention, Inc., Rockville: 2000. p. 1944.

Singh BN, Kim KH. Floating drug delivery systems an approach to

oral controlled drug delivery via gastric retention. J Control Release

;63:235‑59.

Atram SC, Udavant YK, Salunke RJ, Neb GB, Shahi SR, Gulecha BS, et al.

Formulation and evaluation of bilayer tablet containing Metoprolol

succinate and Amlodipine besylate as a model drug for anti hypertensive

therapy. J Pharm Res 2009;2:1335‑47.

Jamunadhevi V, Sahoo PK, Kailasam P. Formulation and in vitro evaluation

of bi‑layer tablet of cyclobenzaprine hydrochloride ER and diclofenac

potassium IR‑ A novel fixed dose combination. Int J Res Pharm Sci

;2:170‑8.

Swamy PV, Kinagi MB, Biradar SS, Gada SN, Shilpa H. Formulation design

and evaluation of bilayer buccal tablets of granisetron hydrochloride.

Ind J Pharm Edu Res 2011;45:242‑7.

Pattanayak DP, Dinda SC. Bilayer tablet formulation of metformin HCl

and glimepiride: A novel approach to improve therapeutic efficacy. Int

J Drug Discov Herb Res 2011;1:1‑4.

Jain J, Marya BH, Mittal RP, Patel M. Formulation and evaluation of

indomethacin bilayer sustained release tablets. Int J PharmTech Res

;3:1132‑8.

Mohindeen S, Jyothi B, Pavani S, Satyanarayana T, Kumar SP, Krishna NS.

Formulation and evaluation of bilayered tablets of metformin

hydrochloride and atorvastatin calcium. Int J Pharm Sci Rev Res

;10:130‑4.

Kumar GV, Babu KA, Ramasanay C. Formulation and evaluation of

bilayered tablets of cefixime trihydrate and dicloxacillin sodium. Int J

PharmTech Res 2011;3:613‑8.

Jadhav RT, Patil PH, Patil PR. Formulation and evaluation of bilayered

tablets of piracetam and vinpocetine. J Chem Pharm Res 2011;3:423‑31.

Rajendran NN, Natarajan R, Subhashini R, Patel H. Formulation and

evaluation of sustained release bilayer tablets of metformin HCl and

pioglitazone HCl. Int J Curr Pharm Res 2011;3:118‑22.

Shirsand SB, Swamy PV, Keshavshetti GG. Design and evaluation of

atenolol bilayer buccal tablets. RGUHS J Pharm Sci 2011;1:4‑10.

Parmar CK, Pednekar PP. Development and evaluation of bilayer tablets

of cefuroxime axetil and potassium clavulanate. Int J Pharm Res Dev

;3:16‑23.

Musle K, Payghan SA, Disuza JI. Fomulation, evaluation and development

of bilayer tablet. Int J Pharm Res Dev 2011;3:80‑7.

Remya PN, Damodharan N, Kumar CV. Formulation and evaluation of

bilayered tablets of ibuprofen and methocarbamol. Int J PharmTech

Res 2010;2:1250‑5.

Gohel MC, Parikh RK, Nagori SA, Jethwa BA. Fabrication and evaluation

of bi‑layer tabletcontaining conventional paracetamol and modified

diclofenac sodium. Indian J Pharm Sci 2010;72:191‑6.

Ramesh DS, Guruvaiah, Harani A. Formulation and evaluation of bilayer

sustained release matrix tablets of Metformin HCl and Pioglitazone.

Amer‑Euras J Sci Res 2010;5:176‑82.

Naeem MA, Mahmood A, Khan SA, Shahiq Z. Development and evaluation

of controlledrelease bilayer tablets containing microencapsulated

tramadol and acetaminophen. Trop J Pharm Res 2010;9:347‑54.

Rathod RT, Misra D. FDC of montelukast with levocetirizine: Focus on

bilayer technology. J Indian Med Assoc 2009;107:562‑4.

Kadam VV, Waghmare MU, Venkatpurwar VP, Pokharkar VB. Preparation

and evaluation of glipizide‑metformin HCl sustained release bilayer

tablet [online]. 2009 [Last cited on 2009 Sep 15]. Available from: http://

www.scientificipca.org/paper/2009/09/15/200909151256230A.doc [Last

accessed on 2011 Jul 1].

Friedl T, Schepky G, inventors; Boehringer Ingelheim USA

Corporation, assignee. Bilayer pharmaceutical tablet comprising

telmisartan and a diuretic and preparation thereof. US patent

A1. 2009 Sept 10.

Bakuridze AD, Maglakelidze GM, Kurdiani NG, Tsagarejshvili NT,

Berashvili DT. Technology of vitamins containing double layer

suppositories. Georgian Med News 2008;158:49‑51.

Ouali A, Azad AK, inventors; Pharmascience Inc, assignee. Stabilized

pharmaceutical composition of nonsteroidal antiinflammatory agent

and a prostaglandin. WO 2000/056339. 2007 Jan 03.

Kohlrausch A, inventor; Boehringer Ingelheim International GmbH,

assignee. Bilayer tablet of telmisartan and simvastatin. US patent

A1. 2006 Apr 13.

De‑fang O, Shu‑fang N, Jin M, Xing‑gang Y, Zhi‑quan S, Wei‑san P.

Compound metformin/glipizide bilayer extended release tablets:

Development and in vitro release. 2005;14:169‑72.